海王生物连收3个涨停板

Core Points - The stock of Haiwang Biological has reached a trading limit, marking three consecutive days of limit-up, with a current price of 3.40 yuan and a trading volume of 2.86 billion shares, resulting in a total transaction amount of 9.12 billion yuan [2] - During the consecutive limit-up period, the stock has increased by 33.33%, with a cumulative turnover rate of 30.09% [2] - The latest total market capitalization of the A-shares is 8.946 billion yuan, with a circulating market capitalization of 8.930 billion yuan [2] Financing Data - As of November 27, the margin trading balance for the stock is 203 million yuan, with a financing balance of 202 million yuan, reflecting an increase of 5.27 million yuan from the previous trading day, a growth of 2.68% [2] - Over the past three days, the financing balance has increased by 26.38 million yuan, representing a growth of 15.01% [2] Trading Activity - The stock has appeared on the Dragon and Tiger list due to a cumulative price deviation of 20% over three trading days and a daily price deviation of 7%, with institutional net purchases amounting to 28.19 million yuan and a cumulative net sale of 30.07 million yuan by the Shenzhen Stock Connect [2] - The trading performance over recent days shows fluctuations in daily price changes and turnover rates, with notable net inflows and outflows of capital [3] Financial Performance - For the first three quarters, the company reported a total operating income of 21.513 billion yuan, a year-on-year decrease of 12.38%, and a net profit of 25.703 million yuan, down 44.39% year-on-year [2] - The basic earnings per share are reported at 0.0098 yuan, with a weighted average return on net assets of 1.42% [2]